Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 2586396)

Published in Peptides on September 30, 2008

Authors

Tobias Inhoff1, Hubert Mönnikes, Steffen Noetzel, Andreas Stengel, Miriam Goebel, Q Thai Dinh, Andrea Riedl, Norbert Bannert, Anna-Sophia Wisser, Bertram Wiedenmann, Burghard F Klapp, Yvette Taché, Peter Kobelt

Author Affiliations

1: Department of Medicine, Division Hepatology, Gastroenterology, and Endocrinology, Charité - Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany.

Articles citing this

The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology (2009) 1.21

Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight. Peptides (2009) 1.19

The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem (2011) 1.05

Lipopolysaccharide differentially decreases plasma acyl and desacyl ghrelin levels in rats: potential role of the circulating ghrelin-acylating enzyme GOAT. Peptides (2010) 0.98

Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice. PLoS One (2010) 0.97

Novel insight in distribution of nesfatin-1 and phospho-mTOR in the arcuate nucleus of the hypothalamus of rats. Peptides (2009) 0.96

Role of ghrelin in the pathophysiology of gastrointestinal disease. Gut Liver (2013) 0.91

Stress-related alterations of acyl and desacyl ghrelin circulating levels: mechanisms and functional implications. Peptides (2011) 0.90

Nesfatin-1--role as possible new potent regulator of food intake. Regul Pept (2010) 0.88

Integrating GHS into the Ghrelin System. Int J Pept (2010) 0.88

The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors. Obes Rev (2013) 0.88

Abdominal surgery inhibits circulating acyl ghrelin and ghrelin-O-acyltransferase levels in rats: role of the somatostatin receptor subtype 2. Am J Physiol Gastrointest Liver Physiol (2011) 0.87

The effects of exercise on food intake and hunger: relationship with acylated ghrelin and leptin. J Sports Sci Med (2011) 0.85

Yin and Yang - the Gastric X/A-like Cell as Possible Dual Regulator of Food Intake. J Neurogastroenterol Motil (2012) 0.84

Hormonal regulation of energy-protein homeostasis in hemodialysis patients: an anorexigenic profile that may predispose to adverse cardiovascular outcomes. Am J Physiol Endocrinol Metab (2010) 0.84

Administration of exogenous acylated ghrelin or rikkunshito, an endogenous ghrelin enhancer, improves the decrease in postprandial gastric motility in an acute restraint stress mouse model. Neurogastroenterol Motil (2014) 0.84

Impairment of ghrelin synthesis in Helicobacter pylori-colonized stomach: new clues for the pathogenesis of H. pylori-related gastric inflammation. World J Gastroenterol (2014) 0.83

New Insights in Anorexia Nervosa. Front Neurosci (2016) 0.81

Ghrelin-Derived Peptides: A Link between Appetite/Reward, GH Axis, and Psychiatric Disorders? Front Endocrinol (Lausanne) (2014) 0.81

Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage. Curr Protein Pept Sci (2011) 0.81

Interactions of gastrointestinal peptides: ghrelin and its anorexigenic antagonists. Int J Pept (2010) 0.80

Regulation of food intake and body weight by recombinant proghrelin. Am J Physiol Endocrinol Metab (2009) 0.80

Plasma nesfatin-1 and glucoregulatory hormone responses to two different anaerobic exercise sessions. Eur J Appl Physiol (2010) 0.78

Dietary Caprylic Acid (C8:0) Does Not Increase Plasma Acylated Ghrelin but Decreases Plasma Unacylated Ghrelin in the Rat. PLoS One (2015) 0.77

Effects of glucose and insulin on acyl ghrelin and desacyl ghrelin, leptin, and adiponectin in pregnant women with diabetes. Metabolism (2009) 0.77

Plasma levels of acylated and total ghrelin in pediatric patients with chronic kidney disease. Pediatr Nephrol (2010) 0.77

Gastric peptides and their regulation of hunger and satiety. Curr Gastroenterol Rep (2012) 0.77

c-Fos induction by gut hormones and extracellular ATP in osteoblastic-like cell lines. Purinergic Signal (2016) 0.76

Unacylated ghrelin suppresses ghrelin-induced neuronal activity in the hypothalamus and brainstem of male rats [corrected]. PLoS One (2014) 0.76

From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation. Int J Mol Sci (2017) 0.76

In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters. Oncotarget (2015) 0.75

Therapeutic Potential of Targeting the Ghrelin Pathway. Int J Mol Sci (2017) 0.75

Control of Food Intake by Gastrointestinal Peptides: Mechanisms of Action and Possible Modulation in the Treatment of Obesity. J Neurogastroenterol Motil (2017) 0.75

Clarifying the Ghrelin System's Ability to Regulate Feeding Behaviours Despite Enigmatic Spatial Separation of the GHSR and Its Endogenous Ligand. Int J Mol Sci (2017) 0.75

The effects of ghrelin on energy balance and psychomotor activity in a goldfish model: an overview. Int J Pept (2011) 0.75

Articles cited by this

Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature (1999) 17.72

Ghrelin induces adiposity in rodents. Nature (2000) 10.18

A role for ghrelin in the central regulation of feeding. Nature (2001) 8.12

Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab (2001) 6.41

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology (2000) 3.80

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology (2001) 3.40

Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature (2006) 3.19

Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature (1998) 2.99

Rhythms of ghrelin, leptin, and sleep in rats: effects of the normal diurnal cycle, restricted feeding, and sleep deprivation. Am J Physiol Regul Integr Comp Physiol (2004) 2.56

Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun (2000) 2.41

PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci (1995) 2.12

Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther (2002) 2.10

Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut (2005) 2.02

Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology (2007) 1.90

Peripheral ghrelin selectively increases Fos expression in neuropeptide Y - synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett (2002) 1.73

Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology (2006) 1.67

Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J Comp Neurol (1998) 1.57

Bombesin, but not amylin, blocks the orexigenic effect of peripheral ghrelin. Am J Physiol Regul Integr Comp Physiol (2006) 1.47

Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab (2004) 1.39

Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol (2000) 1.39

International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacol Rev (2005) 1.35

Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology (2005) 1.32

Ghrelin acts on leptin-responsive neurones in the rat arcuate nucleus. J Neuroendocrinol (2002) 1.13

Nesfatin-1 inhibits NPY neurons in the arcuate nucleus. Brain Res (2008) 1.08

CCK inhibits the orexigenic effect of peripheral ghrelin. Am J Physiol Regul Integr Comp Physiol (2004) 1.07

Intraperitoneal injection of ghrelin induces Fos expression in the paraventricular nucleus of the hypothalamus in rats. Brain Res (2003) 0.98

Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut (2006) 0.97

Intracisternal des-acyl ghrelin inhibits food intake and non-nutrient gastric emptying in conscious rats. Int J Mol Med (2005) 0.96

Effect of CART in the hypothalamic paraventricular nucleus on feeding and uncoupling protein gene expression. Neuroreport (2000) 0.95

Two immunocytochemical protocols for immunofluorescent detection of c-Fos positive neurons in the rat brain. Brain Res Brain Res Protoc (2004) 0.95

Regulation of food intake by acyl and des-acyl ghrelins in the goldfish. Peptides (2006) 0.93

Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology (2007) 0.92

Diurnal rhythms of leptin and ghrelin in the systemic circulation and in the gastric mucosa are related to food intake in rats. Pflugers Arch (2004) 0.90

Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice. Diabetologia (2006) 0.86

Effects of adrenalectomy on CART expression in the rat arcuate nucleus. Synapse (2003) 0.84

Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents. Peptides (2008) 0.82

Co-localization of cart peptide immunoreactivity and nitric oxide synthase activity in rat hypothalamus. Brain Res (2000) 0.81

Articles by these authors

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med (2011) 11.93

A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med (2013) 6.09

Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology (2009) 4.11

Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection. Hepatology (2004) 3.70

Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology (2010) 3.64

Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. Neuroimage (2007) 3.25

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial. J Clin Oncol (2009) 3.18

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study Group. J Clin Oncol (2003) 3.09

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues. Hepatology (2010) 3.02

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology (2012) 3.00

Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy. Hepatology (2006) 2.68

Development of a computer-adaptive test for depression (D-CAT). Qual Life Res (2005) 2.50

Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet (2007) 2.48

Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2004) 2.45

Influenza A viruses target type II pneumocytes in the human lung. J Infect Dis (2012) 2.38

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. J Natl Cancer Inst (2003) 2.19

Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol (2010) 2.18

Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer (2008) 2.16

Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. Neuroendocrinology (2004) 2.16

Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology (2003) 2.16

Successful recanalization of a completely obliterated esophageal stricture by using an endoscopic rendezvous maneuver. Gastrointest Endosc (2005) 2.12

Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet (2013) 2.10

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer (2008) 2.08

A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med (2007) 2.08

Mechanisms and treatment of postoperative ileus. Arch Surg (2003) 2.01

Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer. J Virol (2009) 2.00

First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet (2008) 1.98

Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index. Peptides (2012) 1.95

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology (2009) 1.92

A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet (2006) 1.90

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology (2003) 1.86

Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12,134 examinations (Berlin colonoscopy project 3, BECOP-3). Gut (2012) 1.83

Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol (2009) 1.77

Narrow-band versus white-light high definition television endoscopic imaging for screening colonoscopy: a prospective randomized trial. Gastroenterology (2008) 1.76

Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study. Endocr Relat Cancer (2012) 1.76

Peripheral ghrelin selectively increases Fos expression in neuropeptide Y - synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci Lett (2002) 1.73

Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents. Gastroenterology (2011) 1.71

Consensus guidelines for the management of patients with digestive neuroendocrine tumors--well-differentiated jejunal-ileal tumor/carcinoma. Neuroendocrinology (2007) 1.67

Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol (2007) 1.67

Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am J Respir Crit Care Med (2004) 1.66

Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology (2009) 1.66

Pan-neurotrophin receptor p75 contributes to neuronal hyperreactivity and airway inflammation in a murine model of experimental asthma. Am J Respir Cell Mol Biol (2003) 1.65

Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology (2008) 1.63

[Standardized diagnosing: computer-assisted (CIDI) diagnoses compared to clinically-judged diagnoses in a psychosomatic setting]. Psychother Psychosom Med Psychol (2006) 1.59

Neuronal plasticity of the "brain-skin connection": stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. J Mol Med (Berl) (2007) 1.58

Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis. Liver Int (2011) 1.57

Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1. Am J Physiol Gastrointest Liver Physiol (2013) 1.56

Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J Biol Chem (2002) 1.56

Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res (2008) 1.54

The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. J Clin Invest (2011) 1.53

Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis. J Immunol (2007) 1.51

Data quality of the German screening colonoscopy registry. Endoscopy (2013) 1.48

Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. Cancer Res (2003) 1.48

Bombesin, but not amylin, blocks the orexigenic effect of peripheral ghrelin. Am J Physiol Regul Integr Comp Physiol (2006) 1.47

The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control. Diabetes Care (2002) 1.46

The Perceived Stress Questionnaire (PSQ) reconsidered: validation and reference values from different clinical and healthy adult samples. Psychosom Med (2005) 1.46

Cardiac surgery for carcinoid heart disease in 12 cases. Gen Thorac Cardiovasc Surg (2011) 1.46

Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome. Cancer (2011) 1.46

Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice. J Physiol (2004) 1.45

Development and evaluation of a computer adaptive test for 'Anxiety' (Anxiety-CAT). Qual Life Res (2007) 1.45

Transspecies transmission of the endogenous koala retrovirus. J Virol (2006) 1.45

Autoregulation of Th1-mediated inflammation by twist1. J Exp Med (2008) 1.43

Antireflux 'barriers': problems with patient recruitment for a new endoscopic antireflux procedure. Eur J Gastroenterol Hepatol (2009) 1.43

Arguments pro disinfection in diagnostic electron microscopy: a response to Madeley and Biel. J Infect (2006) 1.42

Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat (2012) 1.38

Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem (2005) 1.37

Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9. Gastroenterology (2002) 1.35

Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol (2011) 1.35

Nibbling at CRF receptor control of feeding and gastrocolonic motility. Trends Pharmacol Sci (2003) 1.35

Fundamentals of neurogastroenterology: basic science. Gastroenterology (2006) 1.34

Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression. Cancer Res (2008) 1.34

Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther (2002) 1.33

Capsaicin-sensitive and -insensitive vagal bronchopulmonary C-fibres in the mouse. J Physiol (2003) 1.33

CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J Neurochem (2004) 1.30

HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease. Front Oncol (2013) 1.30

Inter-disease comparison of research quantity and quality: bronchial asthma and chronic obstructive pulmonary disease. J Asthma (2009) 1.28

A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. J Hepatol (2007) 1.27

Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB. PLoS One (2010) 1.27

Stress and visceral pain: from animal models to clinical therapies. Exp Neurol (2011) 1.25

No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro. PLoS One (2010) 1.25

Early risk factors for miscarriage: a prospective cohort study in pregnant women. Reprod Biomed Online (2008) 1.25

Prenatal stress enhances susceptibility of murine adult offspring toward airway inflammation. J Immunol (2006) 1.24

Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol (2004) 1.23